( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57



Hadeel Ismail Mohsen*, Basim S. H. Ahmed and Adnan I. Ali


Background: Cancer stem cells were identified in several cancers, including PCa, and have been proposed to explain the metastatic capacity, recurrence, and resistance to hormone, radio and chemotherapy in established cell lines from PCa origin, particularly from metastasis. Enzymatic assays and immunohistochemistry have identified several proteins and surface markers that are expressed by CSCs and may be used to identify them in patients. Aim of the study: To assess the immunohistochemical (IHC) expression patterns of the ALDHmarker in PCa, BPH and in apparently normal looking prostate tissue. Methods: A cross-sectional Study carried out at department of histopathology and forensic medicine at Al-Mustansirya medical college and teaching lab of Al-Yarmook Teaching Hospital during a period of one year from (1st of august 2017 to 30th of July 2018). It involved 90 specimens; and these specimens were divided into the following: 60 of them were collected retrospectively depending on the archived files of patients diagnosed either with BPH (30 specimens) or with PCa (30 specimens) in the years 2016 and 2017 in Al-Yarmook Teaching Hospital and in the private labs. The other 30 specimens of normal prostatic tissue were collected prospectively from autopsy presented in forensic medicine directorate during the first three months of 2018. All patients diagnosed with BPH or PCa during 2016 and 2017 were included without any exclusion. Positive control: Human gallbladder tissue for ALDH marker with each run. Results: The mean age of the patients was 73.71 ± 8.15 years. The highest proportion of specimens of PCa (Group A) was graded ≤ 7 by Gleason Grading System (53.3%). There were significant associations (P < 0.05) between all these CSC marker results and prevalence of PCa. Positive ALDH marker result was significantly associated (P=0.024) with high Gleason Grading System. Conclusion: ALDH1 is significantly expressed in prostate carcinomas, and more likely so in cases with Gleason grading system 8.

Keywords: PCa, CSC markers, BPH, Iraq.

[Full Text Article]




    JANUARY issue has been successfully launched on 1 JANUARY 2023.

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 January 2023 Issue has been Published, Kindly check it on

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database